You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 6, December 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Value of Follow-Up After Treatment of Basal Cell Carcinoma

Ernst Epstein, MD

Arch Dermatol. 1973;108(6):798-800.


Abstract

In a study of the value of long-term follow-up after treatment of basal cell carcinoma, new skin cancers were found in 20% of patients examined during a one-year period. The majority of these new skin cancers were unsuspected by the patient. The risk of developing a new skin cancer was directly related to the number of previous basal cell carcinomas. While 20% of the entire group developed new skin cancers, 41% of those who had two or more previous skin cancers developed a new lesion, and of those having had three or more previous carcinomas, 56% developed skin cancers. The author believes that long-term follow-up for skin cancer patients is indicated to detect new tumors, and urges that all patients having had two or more previous basal cell carcinomas be followed up indefinitely.



Author Affiliations

San Francisco

From the Department of Dermatology, University of California, San Francisco Medical Center, San Francisco.


Footnotes

Accepted for publication July 17, 1973.

Reprint requests to 36 S El Camino Real, San Mateo, CA 94401.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer: A Critical Review of the Literature and Meta-analysis
Marcil and Stern
Arch Dermatol 2000;136:1524-1530.
ABSTRACT | FULL TEXT  

Risk of Subsequent Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Among Patients With Prior Skin Cancer
Karagas et al.
JAMA 1992;267:3305-3310.
ABSTRACT  

What Are Adequate Treatment and Follow-up Care for Nonmelanoma Cutaneous Cancer?
Robinson
Arch Dermatol 1987;123:331-333.
ABSTRACT  

Adequate Follow-up for Treated Basal Cell Carcinoma-Reply
Suhge d'Aubermont and Bennett
Arch Dermatol 1986;122:243-244.
ABSTRACT  

Basal Cell Carcinoma With Bony Metastases Producing Myelofibrosis
Jager et al.
Arch Dermatol 1977;113:1288-1289.
ABSTRACT  

Multiple Sequential Skin Cancers: The Risk of Skin Cancer in Patients With Previous Skin Cancer
Bergstresser and Halprin
Arch Dermatol 1975;111:995-996.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.